Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.
Conquer Risk Tactical Rotation CRTBX
- NAV / 1-Day Return 10.82 / +0.84 %
- Total Assets 147.4 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.740%
- Distribution Fee Level High
- Share Class Type No Load
- Category Tactical Allocation
- Investment Style Mid Blend
- Credit Quality / Interest Rate Sensitivity —
- Status Open
- TTM Yield 0.99%
- Turnover 1,644%
USD | NAV as of Sep 26, 2024 | 1-Day Return as of Sep 26, 2024, 10:13 PM GMT+0
Morningstar’s Analysis CRTBX
Will CRTBX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 98.0
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
SPDR® Portfolio S&P 400™ Mid Cap ETF | 36.44 | 54.6 Mil | — |
Direxion Daily Mid Cap Bull 3X ETF | 12.08 | 18.1 Mil | — |
WisdomTree Japan Hedged Equity ETF | 10.24 | 15.3 Mil | — |
Vanguard Total Stock Market ETF | 9.90 | 14.8 Mil | — |
WisdomTree US Quality Dividend Gr ETF | 9.84 | 14.7 Mil | — |
iShares US Pharmaceuticals ETF | 9.76 | 14.6 Mil | — |
The Consumer Staples Sel SectSPDR® ETF | 9.75 | 14.6 Mil | — |
Cash & Cash Equivalents | 2.00 | 3.0 Mil | Cash and Equivalents |